For example, Fang et al. reported that the activation of AMPK/mTOR pathway can suppress the HCC malignant phenotype by inhibiting glycolysis [102]; whereas loss of AMPK activation was associated a poor prognosis in HCC patients [103]. The gene discussed is PRKAA1; the disease is hepatocellular carcinoma.